Souvie Biodelivery
Targeted drug delivery avoiding side effects.
Targeted drug delivery avoiding side effects.
Souvie Biodelivery is a biotechnology startup founded in 2018 with the slogan "Targeted drug delivery avoiding side effects." The company specializes in developing novel drug delivery platforms using nanotechnology, catering to niche markets in the pharmaceutical and healthcare industries. Its most recent achievement includes securing a $225.00K grant investment from the National Science Foundation in 03 February 2021.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Grant | $225.00K | 1 |
|
03 Feb 2021 |
No recent news or press coverage available for Souvie Biodelivery.
We care about your data, and we'd love to use cookies make your experience better.
